Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial

AIMS: Previous uncontrolled studies suggested a possible benefit of intravenous immunoglobulin (IVIg) in parvovirus B19 (B19V)‐related dilated cardiomyopathy (DCM). This randomized, double‐blind, placebo‐controlled, single‐centre trial investigated the benefits of IVIg beyond conventional therapy in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Heart Fail
Hlavní autoři: Hazebroek, Mark R., Henkens, Michiel T.H.M., Raafs, Anne G., Verdonschot, Job A.J., Merken, Jort J., Dennert, Robert M., Eurlings, Casper, Abdul Hamid, Myrurgia A., Wolffs, Petra F.G., Winkens, Bjorn, Brunner‐La Rocca, Hans‐Peter, Knackstedt, Christian, van Paassen, Pieter, van Empel, Vanessa P.M., Heymans, Stephane R.B.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2021
Témata:
Focus on Myocarditis, Cardiomyopathy and Amyloidosis
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8048650/
https://ncbi.nlm.nih.gov/pubmed/33347677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.2082
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky